Vaidya Sane Ayurved Laboratories Ltd.
NSE: MADHAVBAUG
₹199.95
₹6.55
(3.39%)
As on 22-May-2026IST
Market cap
₹210 Cr
Revenue (TTM)
₹90 Cr
P/E Ratio
23.4
P/B Ratio
3.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹7 Cr
-
ROE
13.7 %
-
ROCE
16.7 %
-
Industry P/E
24.23
-
EV/EBITDA
11.8
-
Debt to Equity
0
-
Book Value
₹59.4
-
EPS
₹6.8
-
Face value
10
-
Shares outstanding
10,513,450
7 Years Aggregate
CFO
₹11.16 Cr
EBITDA
₹43.30 Cr
Net Profit
₹17.78 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vaidya Sane Ayur
| -29.7 | 3.9 | -11.1 | 44.5 | -6.0 | -- | -- |
|
BSE Healthcare
| 8.8 | 8.8 | 9.7 | 11.0 | 27.5 | 14.1 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Vaidya Sane Ayur
| 109.1 | -36.9 | 17.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vaidya Sane Ayur
|
200.0 | 210.2 | 89.9 | 7.2 | -- | 13.7 | 23.4 | 3.4 |
| 5.9 | 7.1 | 0.5 | -0.1 | -89.9 | -- | -- | 0.6 | |
| 31.6 | 18.0 | 8.0 | 0.6 | 13.8 | 5.5 | 28.6 | 1.4 | |
| 649.8 | 8,083.3 | 469.1 | 90.7 | -- | 39 | 89.1 | 19.2 | |
| 211.3 | 274.5 | 127.7 | -24.3 | -20.8 | -325.5 | -- | 55.0 | |
| 21.6 | 37.1 | 49.3 | 0.8 | 1.6 | 4.5 | 48.8 | 2.2 | |
| 39.0 | 37.7 | 69.9 | 1.8 | 3.3 | 4.1 | 21.3 | 1.1 | |
| 175.9 | 276.9 | 162.9 | 9.8 | -- | 32.2 | 16.2 | -- | |
| 108.4 | 69.8 | 65.4 | 2.8 | 6.6 | 12.1 | 25.1 | 2.8 | |
| 34.7 | 32.6 | 71.8 | 2.8 | -- | 18.2 | 14 | 2.0 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Vaidya Sane Ayur
Manufacture of ayurvedic' or unani' pharmaceutical preparation
-
Incorporated
1999
-
Chairman
--
-
Managing Director
Rohit Madhav Sane
-
Headquarters
Pune, Maharashtra
-
Website
Looking for more details about Vaidya Sane Ayurved Laboratories Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Vaidya Sane Ayur
What is the current share price of Vaidya Sane Ayurved Laboratories Ltd Today?
The share price of Vaidya Sane Ayurved Laboratories Ltd is ₹199.95 (NSE) as of 22-May-2026 IST. Vaidya Sane Ayurved Laboratories Ltd has given a return of -6.02% in the last 3 years.
What is the current PB & PE ratio of Vaidya Sane Ayurved Laboratories Ltd?
The P/E ratio of Vaidya Sane Ayurved Laboratories Ltd is 23.39 times as on 22-May-2026, a 3 discount to its peers’ median range of 24.23 times.
The P/B ratio of Vaidya Sane Ayurved Laboratories Ltd is 3.36 times as on 22-May-2026, a 70 discount to its peers’ median range of 11.30 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
13.81
|
1.58
|
|
2024
|
92.39
|
4.34
|
|
2023
|
51.12
|
6.11
|
|
2022
|
59.10
|
5.71
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Vaidya Sane Ayurved Laboratories Ltd?
The 52-week high and low of Vaidya Sane Ayurved Laboratories Ltd are Rs 335.00 and Rs 137.50 as of 24-May-2026.
What is the market cap of Vaidya Sane Ayurved Laboratories Ltd?
Vaidya Sane Ayurved Laboratories Ltd has a market capitalisation of ₹ 210 Cr as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Vaidya Sane Ayurved Laboratories Ltd?
Before investing in Vaidya Sane Ayurved Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.